Resultados de la búsqueda 11-20 of 9925 for monoclonal antibody

  1. Hematología - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells ...

  2. Hematología - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as rituximab, may block cancer growth in ... monoclonal antibody, and compare them with clinical outcomes. Alternate ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such ... Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin.

  4. Hematología - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as rituximab, may block cancer growth in ... monoclonal antibody, and compare them with clinical outcomes. Alternate ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such ... Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin.

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such ... Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin.

  7. Hematología - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as rituximab, may block cancer growth in ... monoclonal antibody, and compare them with clinical outcomes. Alternate ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells ...

  9. Hematología - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...